But a current spate of disquieting clinical trials involving highprofile
drugs including Avandia (rosiglitazone) is prompting researchers to reevaluate
this reliance on surrogate markers (see 'Surrogates beneath suspicion'). "It's
been a watershed year," says Harlan Krumholtz, a cardiologist at Yale
University. "It's shaking assumptions about how we needs louis vuitton uk bechristian
louboutin salethese drugs."
Nobody is saying that surrogate indicators must be abandoned altogether.
Several well known drugs around the market right now, including the breast
cancer drug Gleevac (imatinib) and HIV fighting antiretrovirals, had louis vuitton outlet uk
approved depending on surrogate endpoints, and scandals are uncommon. "You do
not desire to deprive the public of a drug that possibly operates," says Arthur
Schatzkin, chief of nutritional epidemiology at the National Cancer Institute in
Bethesda, Maryland. "On the other hand, you do not desire to place one thing on
the market place which is dangerous. That is the type of thing that individuals
at the FDA [Food and Drug Administration] tear their hair out over."
One difficulty may be the struggle to show that achristian louboutin outlet
ukis causally connected to illness out come, as an alternative to merely a
correlate. Simply because patients with flu have a fever, as an louis vuitton uk bags sale,
doesn't mean that treating the fever will clear the infection. Absolute
self-confidence inside a surrogate needs comprehensive information of the
pathways top to dis ease.
http://www.addthis.com/
No comments:
Post a Comment